Command Palette

Search for a command to run...

Clinical Trials · NCT03862716

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Population Health Research Institute
Enrollment
159
Start date
Apr 2019
Locations
8 sites, Canada
Primary endpoint
Proportion of participants achieving drug-free diabetes remission
View Liraglutide compound reference